BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2328319)

  • 1. Novel compound heterozygous SPTA1 mutations in a patient with hereditary elliptocytosis.
    Ma S; Qin J; Wei A; Li X; Qin Y; Liao L; Lin F
    Mol Med Rep; 2018 Apr; 17(4):5903-5911. PubMed ID: 29484404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When alpha spectrin null alleles meet low expression alpha spectrin polymorphisms.
    Fermo E; Zaninoni A; Vercellati C; Marcello AP; Bestetti I; Castronovo P; Fattizzo B; Barcellini W; Bianchi P
    Br J Haematol; 2023 Nov; 203(4):684-687. PubMed ID: 37565283
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi-center registry.
    Songdej D; Surapolchai P; Komwilaisak P; Sripornsawan P; Lauhasurayotin S; Teawtrakul N; Rungjirajittranon T; Tantiworawit A; Sinlapamongkolkul P; Torcharus K; Sutcharitchan P; Pongtanakul B; Sirachainan N; Charoenkwan P
    Ann Hematol; 2024 Feb; 103(2):385-393. PubMed ID: 37996759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous SPTA1-associated hereditary pyropoikilocytosis presenting as hydrops fetalis.
    Brancamp R; Hughes CE; Dar A; Polic A; Zuckerwise LC; Booth GS
    Transfusion; 2024 Jan; 64(1):189-193. PubMed ID: 38031483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insane in the membrane: A case of hereditary spherocytic pyropoikilocytosis.
    Gibson SJ; Kalfa TA; DeStefano CB
    Am J Hematol; 2022 Oct; 97(10):1384-1385. PubMed ID: 35834292
    [No Abstract]   [Full Text] [Related]  

  • 6. Case Report: α-Spectrin Mutation Associated with αLELY Polymorphism Responsible for Hereditary Pyropoikilocytosis.
    Sánchez Villalobos M; Salido Fiérrez E; Martínez Nieto J; García Garay MC; Beltrán Videla A; Pérez Oliva AB; Blanquer Blanquer M; Moraleda Jiménez JM
    Hematol Rep; 2022 Oct; 14(4):300-304. PubMed ID: 36278520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome analysis to detect congenital hemolytic anemia mimicking congenital dyserythropoietic anemia.
    Hamada M; Doisaki S; Okuno Y; Muramatsu H; Hama A; Kawashima N; Narita A; Nishio N; Yoshida K; Kanno H; Manabe A; Taga T; Takahashi Y; Miyano S; Ogawa S; Kojima S
    Int J Hematol; 2018 Sep; 108(3):306-311. PubMed ID: 29936674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel exon 2 α spectrin mutation and intragenic crossover: three morphological phenotypes associated with four distinct α spectrin defects.
    Swierczek S; Agarwal AM; Naidoo K; Lorenzo FR; Whisenant J; Nussenzveig RH; Agarwal N; Coetzer TL; Prchal JT
    Haematologica; 2013 Dec; 98(12):1972-9. PubMed ID: 24077844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of assembly of the non-covalent spectrin tetramerization domain from intrinsically disordered partners.
    Hill SA; Kwa LG; Shammas SL; Lee JC; Clarke J
    J Mol Biol; 2014 Jan; 426(1):21-35. PubMed ID: 24055379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional effects of hereditary hemolytic anemia-associated point mutations in the alpha spectrin tetramer site.
    Gaetani M; Mootien S; Harper S; Gallagher PG; Speicher DW
    Blood; 2008 Jun; 111(12):5712-20. PubMed ID: 18218854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexibility of the alpha-spectrin N-terminus by EPR and fluorescence polarization.
    Cherry L; Fung LW; Menhart N
    Biophys J; 2000 Jul; 79(1):526-35. PubMed ID: 10866978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocytes carrying mutations in spectrin and protein 4.1 show differing sensitivities to invasion by Plasmodium falciparum.
    Facer CA
    Parasitol Res; 1995; 81(1):52-7. PubMed ID: 7724514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two elliptocytogenic alpha I/74 variants of the spectrin alpha I domain. Spectrin Culoz (GGT----GTT; alpha I 40 Gly----Val) and spectrin Lyon (CTT----TTT; alpha I 43 Leu---Phe).
    Morlé L; Roux AF; Alloisio N; Pothier B; Starck J; Denoroy L; Morlé F; Rudigoz RC; Forget BG; Delaunay J
    J Clin Invest; 1990 Aug; 86(2):548-54. PubMed ID: 2384601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sp alpha V/41: a common spectrin polymorphism at the alpha IV-alpha V domain junction. Relevance to the expression level of hereditary elliptocytosis due to alpha-spectrin variants located in trans.
    Alloisio N; Morlé L; Maréchal J; Roux AF; Ducluzeau MT; Guetarni D; Pothier B; Baklouti F; Ghanem A; Kastally R; Delaunay J
    J Clin Invest; 1991 Jun; 87(6):2169-77. PubMed ID: 2040699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutation in the beta-spectrin gene associated with alpha I/74 hereditary elliptocytosis. Implications for the mechanism of spectrin dimer self-association.
    Tse WT; Lecomte MC; Costa FF; Garbarz M; Feo C; Boivin P; Dhermy D; Forget BG
    J Clin Invest; 1990 Sep; 86(3):909-16. PubMed ID: 1975598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four different mutations in codon 28 of alpha spectrin are associated with structurally and functionally abnormal spectrin alpha I/74 in hereditary elliptocytosis.
    Coetzer TL; Sahr K; Prchal J; Blacklock H; Peterson L; Koler R; Doyle J; Manaster J; Palek J
    J Clin Invest; 1991 Sep; 88(3):743-9. PubMed ID: 1679439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common type of the spectrin alpha I 46-50a-kD peptide abnormality in hereditary elliptocytosis and pyropoikilocytosis is associated with a mutation distant from the proteolytic cleavage site. Evidence for the functional importance of the triple helical model of spectrin.
    Gallagher PG; Tse WT; Coetzer T; Lecomte MC; Garbarz M; Zarkowsky HS; Baruchel A; Ballas SK; Dhermy D; Palek J
    J Clin Invest; 1992 Mar; 89(3):892-8. PubMed ID: 1541680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary pyropoikilocytosis and elliptocytosis in a white French family with the spectrin alpha I/74 variant related to a CGT to CAT codon change (Arg to His) at position 22 of the spectrin alpha I domain.
    Garbarz M; Lecomte MC; Féo C; Devaux I; Picat C; Lefebvre C; Galibert F; Gautero H; Bournier O; Galand C
    Blood; 1990 Apr; 75(8):1691-8. PubMed ID: 2328319
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.